Bayesian Capital Management’s Criteo S.A. CRTO Stock Holding History

Bayesian Capital Management’s Portfolio CRTO Stock Details CRTO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-12,400	Closed	-$280K	–	211
2025 Q3	$280K	Buy	+12,400	New	+$290K	0.06%	391
2025 Q2	–	Sell	-12,769	Closed	-$452K	–	605
2025 Q1	$452K	Buy	+12,769	New	+$496K	0.07%	319
2024 Q4	–	Sell	-5,142	Closed	-$207K	–	741
2024 Q3	$207K	Buy	+5,142	New	+$226K	0.02%	558
2023 Q3	–	Sell	-6,400	Closed	-$216K	–	747
2023 Q2	$216K	Buy	+6,400	New	+$206K	0.02%	625
2019 Q2	–	Sell	-17,400	Closed	-$349K	–	538
2019 Q1	$349K	Buy	+17,400	New	+$443K	0.07%	360
2018 Q3	–	Sell	-28,724	Closed	-$944K	–	653
2018 Q2	$944K	Buy	28,724 +2,800	+11%	+$77.1K	0.21%	119
2018 Q1	$670K	Buy	+25,924	New	+$704K	0.17%	196
2017 Q1	–	Sell	-16,400	Closed	-$674K	–	456
2016 Q4	$674K	Buy	+16,400	New	+$639K	0.17%	233
2016 Q2	–	Sell	-7,617	Closed	-$315K	–	419
2016 Q1	$315K	Buy	+7,617	New	+$266K	0.3%	135

Other funds holding CRTO

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Senvest Management New York $3.41B AUM 66.27% 1-Year Est. Return

DnB Asset Management Oslo, Norway $35.7B AUM 27.58% 1-Year Est. Return

BCM

BlueCrest Capital Management St Helier, Jersey $3.04B AUM 26.78% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

NIMC

Nierenberg Investment Management Company Camas, Washington $201M AUM 20.14% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Bayesian Capital Management's CRTO Position: Q4 2025 in Review

Bayesian Capital Management sold out of Criteo S.A. (CRTO) in Q4 2025, closing a stake of 12,400 shares — an estimated $280K sold.

Bayesian Capital Management first reported a position in CRTO in Q1 2016 and held it in 9 quarters. The position peaked at $944K in Q2 2018. 142 funds tracked by Wall St. Rank hold CRTO as of Q4 2025.

Bayesian Capital Management reported no remaining Criteo S.A. position as of Q4 2025 after selling out during the quarter.
Bayesian Capital Management sold 12,400 Criteo S.A. shares in Q4 2025, an estimated $280K.
Bayesian Capital Management first reported a position in Criteo S.A. in Q1 2016 and held it in 9 quarters.
Bayesian Capital Management's Criteo S.A. position peaked at $944K in Q2 2018.
142 funds tracked by Wall St. Rank held Criteo S.A. as of Q4 2025.

Based on Bayesian Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.